Related Experiment Video
Updated: Sep 23, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Impaired Global Longitudinal Strain Is Associated with Cardiovascular Events in Hodgkin Lymphoma Survivors
Elissa A S Polomski1, Julius C Heemelaar1, Augustinus D G Krol2
1Department of Cardiology, Heart Lung Center, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Insights
Thoracic irradiation for classic Hodgkin lymphoma (CHL) survivors increases cardiovascular risks. Impaired left ventricular (LV) function, particularly global longitudinal strain (GLS), is linked to cardiac events and death.
Area of Science:
- Cardiology
- Oncology
- Radiotherapy
Background:
- Thoracic irradiation for classic Hodgkin lymphoma (CHL) improves survival but elevates cardiovascular event risk.
- Left ventricular ejection fraction (LVEF) assesses LV function, while global longitudinal strain (GLS) detects early subclinical dysfunction.
Purpose of the Study:
- To determine if conventional echocardiographic parameters and GLS predict cardiovascular events in CHL survivors.
- To evaluate the association between LV dysfunction and long-term cardiac outcomes post-radiotherapy.
Main Methods:
- 129 CHL patients treated with radiotherapy, with echocardiography >10 years post-diagnosis, were analyzed.
- Multivariable Cox regression assessed the composite endpoint of cardiac death/cardiovascular events and competing noncardiac death.
- Echocardiographic parameters including GLS, LVEF, and E/e’ were evaluated.
Main Results:
- Impaired GLS (> -16%) was significantly associated with a nearly four-fold increased risk of cardiac events (HR=3.95, p<0.001).
- Reduced LVEF (<50%) (HR=2.99, p=0.016) and elevated E/e’ (HR=1.16, p<0.001) also predicted adverse outcomes.
- No assessed parameters correlated with noncardiac death.
Conclusions:
- Left ventricular dysfunction, including impaired GLS, is a significant predictor of cardiovascular events and cardiac death in CHL survivors.
- Echocardiographic parameters like GLS and LVEF are crucial for risk stratification in this patient population.
- Long-term cardiac monitoring is essential for CHL survivors treated with thoracic irradiation.
Abstract:
Background: Treatment with thoracic irradiation for classic Hodgkin lymphoma (CHL) leads to improved survival but also increases the risk of cardiovascular events. Left ventricular (LV) dysfunction is usually assessed by echocardiographic left ventricular ejection fraction (LVEF), whereas global longitudinal strain (GLS) can detect early subclinical LV dysfunction. The purpose of this study was to evaluate if conventional echocardiographic parameters and GLS are associated with cardiovascular events during long-term follow-up. Methods: 161 consecutive CHL patients treated with radiotherapy who underwent echocardiography > 10 years after diagnosis were assessed for eligibility. Multivariable cause-specific Cox regression was performed for a composite outcome of cardiac death and cardiovascular events and the competing outcome of noncardiac death. Results: 129 patients (61.2% female, N = 79) with a mean age of 46.3 ± 11.0 years at index visit were eligible for analysis. GLS was impaired in 51 patients (39.5%) and 10.9% had a LVEF of< 50%. The median E/e’ was 9.2 [7.2;12.7]. Adjusted for confounders, GLS > −16% showed a significant association with a near four-fold risk of the composite endpoint (HR = 3.95, 95% CI: 1.83−8.52, p < 0.001). LVEF < 50% (HR = 2.99, p = 0.016) and E/e’ (HR = 1.16, p < 0.001) also showed a significant relationship with the outcome. None of the aforementioned parameters were associated with the competing outcome. Conclusions: This study shows that LV dysfunction including impaired GLS in CHL survivors is associated with cardiovascular events and cardiac death.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Longitudinal Research
Cardiomyopathy IV: Restrictive Cardiomyopathy
Longitudinal Studies

